Erratum: Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein (Neuron (2015) 85(1) (76–87), (S0896627314010812), (10.1016/j.neuron.2014.11.027));Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein

Neuron

Volumn 85, Issue 1, 2015, Pages 76-87

  Dhungel, Nripesh ^a   Eleuteri, Simona ^b   Li, Ling bo ^c,d   Kramer, Nicholas J ^a   Chartron, Justin W ^a,c   Spencer, Brian ^b   Kosberg, Kori ^b   Fields, Jerel Adam ^e   Stafa, Klodjan ^e   Adame, Anthony ^b   Lashuel, Hilal ^f   Frydman, Judith ^a,c   Shen, Kang ^c,d   Masliah, Eliezer ^b,e   Gitler, Aaron D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; SORTILIN; CAENORHABDITIS ELEGANS PROTEIN; EIF4G1 PROTEIN, MOUSE; INITIATION FACTOR 4G; SACCHAROMYCES CEREVISIAE PROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN; VESICULAR TRANSPORT PROTEIN; VPS35 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; EIF4G1 GENE; GENE; GENE INTERACTION; IN VITRO STUDY; MOUSE; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FOLDING; UPREGULATION; VPS35 GENE; YEAST; ANIMAL; GENETICS; SACCHAROMYCES CEREVISIAE; TRANSGENIC MOUSE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ALPHA-SYNUCLEIN; ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; EUKARYOTIC INITIATION FACTOR-4G; MICE; MICE, TRANSGENIC; PARKINSON DISEASE; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 84920740324     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2022.12.020     Document Type: Erratum

References (75)

1. Bar-On P., Crews L., Koob A.O., Mizuno H., Adame A., Spencer B., Masliah E. Statins reduce neuronal alpha-synuclein aggregation in invitro models of Parkinson's disease. J.Neurochem. 2008, 105:1656-1667.
2. Blanckenberg J., Ntsapi C., Carr J.A., Bardien S. EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa. Neurobiol. Aging 2014, 35:e1-e3. e3.
3. Bonifati V. Genetics of Parkinson's disease-state of the art, 2013. Parkinsonism Relat. Disord. 2014, 20(1):S23-S28.
4. Boyle E.I., Weng S., Gollub J., Jin H., Botstein D., Cherry J.M., Sherlock G. GO:TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 2004, 20:3710-3715.
5. Burd C., Cullen P.J. Retromer: a master conductor of endosome sorting. Cold Spring Harb. Perspect. Biol. 2014, 6:a016774. 10.1101/cshperspect.a016774.
6. Chartier-Harlin M.C., Dachsel J.C., Vilariño-Güell C., Lincoln S.J., Leprêtre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.S., et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am. J. Hum. Genet. 2011, 89:398-406.
7. Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., Yoo S.J., Hay B.A., Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006, 441:1162-1166.
8. Clarkson B.K., Gilbert W.V., Doudna J.A. Functional overlap between eIF4G isoforms in Saccharomyces cerevisiae. PLoS ONE 2010, 5:e9114.
9. Collins S.R., Schuldiner M., Krogan N.J., Weissman J.S. A strategy for extracting and analyzing large-scale quantitative epistatic interaction data. Genome Biol. 2006, 7:R63.
10. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006, 313:324-328.
11. Dennes A., Madsen P., Nielsen M.S., Petersen C.M., Pohlmann R. The yeast Vps10p cytoplasmic tail mediates lysosomal sorting in mammalian cells and interacts with human GGAs. J.Biol. Chem. 2002, 277:12288-12293.
12. Do C.B., Tung J.Y., Dorfman E., Kiefer A.K., Drabant E.M., Francke U., Mountain J.L., Goldman S.M., Tanner C.M., Langston J.W., et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet. 2011, 7:e1002141.
13. Forman M.S., Trojanowski J.Q., Lee V.M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 2004, 10:1055-1063.
14. Games D., Seubert P., Rockenstein E., Patrick C., Trejo M., Ubhi K., Ettle B., Ghassemiam M., Barbour R., Schenk D., et al. Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein. Am. J. Pathol. 2013, 182:940-953.
15. Gitler A.D. Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease?. Neurosignals 2008, 16:52-62.
16. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., Caldwell K.A., Caldwell G.A., Cooper A.A., Rochet J.C., Lindquist S. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 2009, 41:308-315.
17. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D.M., Doheny K.F., Paschall J., Pugh E., et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 2010, 42:781-785.
18. Harrison M.S., Hung C.S., Liu T.T., Christiano R., Walther T.C., Burd C.G. A mechanism for retromer endosomal coat complex assembly with cargo. Proc. Natl. Acad. Sci. USA 2014, 111:267-272.
19. Hirling H., Steiner P., Chaperon C., Marsault R., Regazzi R., Catsicas S. Syntaxin 13 is a developmentally regulated SNARE involved in neurite outgrowth and endosomal trafficking. Eur. J. Neurosci. 2000, 12:1913-1923.
20. Hu F., Padukkavidana T., Vægter C.B., Brady O.A., Zheng Y., Mackenzie I.R., Feldman H.H., Nykjaer A., Strittmatter S.M. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 2010, 68:654-667.
21. A two-stage meta-analysisidentifies several new loci for Parkinson's disease. PLoS Genet. 2011, 7:e1002142. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2)Wellcome Trust Case Control Consortium 2 (WTCCC2).
22. Jankovic J. Parkinson's disease: clinical features and diagnosis. J.Neurol. Neurosurg. Psychiatry 2008, 79:368-376.
23. Klassen M.P., Shen K. Wnt signaling positions neuromuscular connectivity by inhibiting synapse formation in C elegans. Cell 2014, 130:104-116.
24. Krebs C.E., Karkheiran S., Powell J.C., Cao M., Makarov V., Darvish H., Di Paolo G., Walker R.H., Shahidi G.A., Buxbaum J.D., et al. The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures. Hum. Mutat. 2013, 34:1200-1207.
25. Lane R.F., St George-Hyslop P., Hempstead B.L., Small S.A., Strittmatter S.M., Gandy S. Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes. J.Neurosci. 2012, 32:14080-14086.
26. Lee V.M., Trojanowski J.Q. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron 2006, 52:33-38.
27. Lesage S., Condroyer C., Klebe S., Lohmann E., Durif F., Damier P., Tison F., Anheim M., Honoré A., Viallet F., et al. EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?. Neurobiol. Aging 2012, 33:e1-e5. French Parkinson's Disease Genetics Study Group.
28. Lewis J., Golde T.E. Sorting out frontotemporal dementia?. Neuron 2010, 68:601-603.
29. Li H., Teo Y.Y., Tan E.K. Patterns of linkage disequilibrium of LRRK2 across different races: implications for genetic association studies. PLoS ONE 2013, 8:e75041.
30. Lill C.M., Roehr J.T., McQueen M.B., Kavvoura F.K., Bagade S., Schjeide B.M., Schjeide L.M., Meissner E., Zauft U., Allen N.C., et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 2012, 8:e1002548. 23andMe Genetic Epidemiology of Parkinson's Disease Consortium, International Parkinson's Disease Genomics ConsortiumInternational Parkinson's Disease Genomics Consortium, Parkinson's Disease GWAS ConsortiumParkinson's Disease GWAS Consortium, Wellcome Trust Case Control Consortium 2)Wellcome Trust Case Control Consortium 2).
31. Luk K.C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
32. MacLeod D.A., Rhinn H., Kuwahara T., Zolin A., Di Paolo G., McCabe B.D., Marder K.S., Honig L.S., Clark L.N., Small S.A., Abeliovich A. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 2013, 77:425-439.
33. Martin I., Kim J.W., Lee B.D., Kang H.C., Xu J.C., Jia H., Stankowski J., Kim M.S., Zhong J., Kumar M., et al. Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell 2014, 157:472-485.
34. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000, 287:1265-1269.
35. Massano J., Bhatia K.P. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb. Perspect. Med. 2012, 2:a008870.
36. Mazzulli J.R., Xu Y.H., Sun Y., Knight A.L., McLean P.J., Caldwell G.A., Sidransky E., Grabowski G.A., Krainc D. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146:37-52.
37. Mecozzi V.J., Berman D.E., Simoes S., Vetanovetz C., Awal M.R., Patel V.M., Schneider R.T., Petsko G.A., Ringe D., Small S.A. Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 2014, 10:443-449.
38. Miklavc P., Ehinger K., Thompson K.E., Hobi N., Shimshek D.R., Frick M. Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis. PLoS ONE 2014, 9:e84926.
39. Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simón-Sánchez J., Schulte C., Lesage S., Sveinbjörnsdóttir S., et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649. International Parkinson Disease Genomics Consortium.
40. Nalls M.A., Pankratz N., Lill C.M., Do C.B., Hernandez D.G., Saad M., DeStefano A.L., Kara E., Bras J., Sharma M., et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 2014, 46:989-993. International Parkinson's Disease Genomics Consortium (IPDGC), Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI)Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe23andMe, GenePDGenePD, NeuroGenetics Research Consortium (NGRC)NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG)Hussman Institute of Human Genomics (HIHG), Ashkenazi Jewish Dataset InvestigatorAshkenazi Jewish Dataset Investigator, Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE)Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE), North American Brain Expression Consortium (NABEC)North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC)United Kingdom Brain Expression Consortium (UKBEC), Greek Parkinson's Disease ConsortiumGreek Parkinson's Disease Consortium, Alzheimer Genetic Analysis GroupAlzheimer Genetic Analysis Group.
41. Nalls M.A., Saad M., Noyce A.J., Keller M.F., Schrag A., Bestwick J.P., Traynor B.J., Gibbs J.R., Hernandez D.G., Cookson M.R., et al. Genetic comorbidities in Parkinson's disease. Hum. Mol. Genet. 2014, 23:831-841. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2)Wellcome Trust Case Control Consortium 2 (WTCCC2), North American Brain Expression Consortium (NABEC)North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC)United Kingdom Brain Expression Consortium (UKBEC).
42. Nishioka K., Funayama M., Vilariño-Güell C., Ogaki K., Li Y., Sasaki R., Kokubo Y., Kuzuhara S., Kachergus J.M., Cobb S.A., et al. EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population. Parkinsonism Relat. Disord. 2014, 20:659-661.
43. Novarino G., Fenstermaker A.G., Zaki M.S., Hofree M., Silhavy J.L., Heiberg A.D., Abdellateef M., Rosti B., Scott E., Mansour L., et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 2014, 343:506-511.
44. Oromendia A.B., Dodgson S.E., Amon A. Aneuploidy causes proteotoxic stress in yeast. Genes Dev. 2012, 26:2696-2708.
45. Ou C.Y., Poon V.Y., Maeder C.I., Watanabe S., Lehrman E.K., Fu A.K., Park M., Fu W.Y., Jorgensen E.M., Ip N.Y., Shen K. Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell 2010, 141:846-858.
46. Outeiro T.F., Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 2003, 302:1772-1775.
47. Overk C.R., Kelley C.M., Mufson E.J. Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2009, 35:415-425.
48. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J.M., Chung J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006, 441:1157-1161.
49. Park E.H., Walker S.E., Lee J.M., Rothenburg S., Lorsch J.R., Hinnebusch A.G. Multiple elements in the eIF4G1 N-terminus promote assembly of eIF4G1•PABP mRNPs invivo. EMBO J. 2011, 30:302-316.
50. Patil C., Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr. Opin. Cell Biol. 2001, 13:349-355.
51. Quadri M., Fang M., Picillo M., Olgiati S., Breedveld G.J., Graafland J., Wu B., Xu F., Erro R., Amboni M., et al. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Hum. Mutat. 2013, 34:1208-1215. International Parkinsonism Genetics Network.
52. Reitz C. The role of intracellular trafficking and the VPS10d receptors in Alzheimer's disease. Future Neurol. 2012, 7:423-431.
53. Reitz C., Tosto G., Vardarajan B., Rogaeva E., Ghani M., Rogers R.S., Conrad C., Haines J.L., Pericak-Vance M.A., Fallin M.D., et al. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease riskand processing of the amyloid precursor protein (APP). Transl. Psychiatr. 2013, 3:e256. Alzheimer's Disease Genetics Consortium (ADGC).
54. Rockenstein E., Mallory M., Hashimoto M., Song D., Shults C.W., Lang I., Masliah E. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J.Neurosci. Res. 2002, 68:568-578.
55. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 2009, 41:1303-1307.
56. Schütz P., Bumann M., Oberholzer A.E., Bieniossek C., Trachsel H., Altmann M., Baumann U. Crystal structure of the yeast eIF4A-eIF4G complex: an RNA-helicase controlled by protein-protein interactions. Proc. Natl. Acad. Sci. USA 2008, 105:9564-9569.
57. Seaman M.N., Marcusson E.G., Cereghino J.L., Emr S.D. Endosome to Golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29, VPS30, and VPS35 gene products. J.Cell Biol. 1997, 137:79-92.
58. Seaman M.N., McCaffery J.M., Emr S.D. A membrane coat complex essential for endosome-to-Golgi retrograde transport in yeast. J.Cell Biol. 1998, 142:665-681.
59. Shorter J. Hsp104: a weapon to combat diverse neurodegenerative disorders. Neurosignals 2008, 16:63-74.
60. Siitonen A., Majounie E., Federoff M., Ding J., Majamaa K., Singleton A.B. Mutations in EIF4G1 are not a common cause of Parkinson's disease. Eur. J. Neurol. 2013, 20:e59.
61. Simón-Sánchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
62. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
63. Smith W.W., Pei Z., Jiang H., Moore D.J., Liang Y., West A.B., Dawson V.L., Dawson T.M., Ross C.A. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. USA 2005, 102:18676-18681.
64. Spencer B., Potkar R., Trejo M., Rockenstein E., Patrick C., Gindi R., Adame A., Wyss-Coray T., Masliah E. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J.Neurosci. 2009, 29:13578-13588.
65. Sudhaman S., Behari M., Govindappa S.T., Muthane U.B., Juyal R.C., Thelma B.K. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians. Neurobiol. Aging 2013, 34:e1-e3. e3.
66. Tong A.H., Boone C. Synthetic genetic array analysis in Saccharomyces cerevisiae. Methods Mol. Biol. 2006, 313:171-192.
67. Trinh J., Farrer M. Advances in the genetics of Parkinson disease. Nat. Rev. Neurol. 2013, 9:445-454.
68. Tucci A., Charlesworth G., Sheerin U.M., Plagnol V., Wood N.W., Hardy J. Study of the genetic variability in a Parkinson's Disease gene: EIF4G1. Neurosci. Lett. 2012, 518:19-22.
69. Vilariño-Güell C., Wider C., Ross O.A., Dachsel J.C., Kachergus J.M., Lincoln S.J., Soto-Ortolaza A.I., Cobb S.A., Wilhoite G.J., Bacon J.A., et al. VPS35 mutations in Parkinson disease. Am. J. Hum. Genet. 2011, 89:162-167.
70. Villa N., Do A., Hershey J.W., Fraser C.S. Human eukaryotic initiation factor 4G (eIF4G) protein binds to eIF3c, -d, and -e to promote mRNA recruitment to the ribosome. J.Biol. Chem. 2013, 288:32932-32940.
71. Volpicelli-Daley L.A., Luk K.C., Patel T.P., Tanik S.A., Riddle D.M., Stieber A., Meaney D.F., Trojanowski J.Q., Lee V.M. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011, 72:57-71.
72. Walter P., Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011, 334:1081-1086.
73. Wan J.Y., Edwards K.L., Hutter C.M., Mata I.F., Samii A., Roberts J.W., Agarwal P., Checkoway H., Farin F.M., Yearout D., Zabetian C.P. Association mapping of the PARK10 region for Parkinson's disease susceptibility genes. Parkinsonism Relat. Disord. 2014, 20:93-98.
74. Xiong Y., Coombes C.E., Kilaru A., Li X., Gitler A.D., Bowers W.J., Dawson V.L., Dawson T.M., Moore D.J. GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet. 2010, 6:e1000902.
75. Yeger-Lotem E., Riva L., Su L.J., Gitler A.D., Cashikar A.G., King O.D., Auluck P.K., Geddie M.L., Valastyan J.S., Karger D.R., et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nat. Genet. 2009, 41:316-323.